Todd Smith is chief executive officer (CEO) of Corium, a commercial-stage biopharmaceutical company focused on neuroscience. He brings more than 30 years of leadership experience spanning commercial operations, business development, and executive management across the biopharmaceutical industry. Throughout his career, he has launched numerous innovative biopharmaceutical products.

Prior to joining Corium, Mr. Smith served as CEO of Valinor Pharma, Iroko Pharmaceuticals, Zyla Life Sciences, and Assertio Therapeutics. Earlier in his career, he served as chief commercial officer (CCO) and head of business development at Horizon Therapeutics and CCO at Tolmar Pharmaceuticals, following commercial leadership roles at Abbott Labs and Fenwal. Mr. Smith currently serves on the boards of BVI Medical, Quetzal Therapeutics and Corium. He earned a B.A. in political science from Norwich University.